BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 27628523)

  • 1. 'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'.
    Lau MS; Mooney P; White W; Appleby V; Moreea S; Haythem I; Elias J; Bundhoo K; Corbett G; Wong L; Tsai HH; Cross S; Hebden J; Hoque S; Sanders D
    BMC Gastroenterol; 2016 Sep; 16():115. PubMed ID: 27628523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Random duodenal biopsy to exclude coeliac disease as a cause of anaemia is not cost-efective and should be replaced with universally performed pre-endoscopy serology in patients on a suspected cancer pathway.
    Herrod PJJ; Lund JN
    Tech Coloproctol; 2018 Feb; 22(2):121-124. PubMed ID: 29476446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coeliac disease detection with an IgA/IgG-deamidated gliadin peptide based point of care test in community pharmacies.
    Lau MS; Sanders DS
    Int J Clin Pharm; 2019 Apr; 41(2):583-588. PubMed ID: 30778740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Detection of Celiac Disease With Measurement of Deamidated Gliadin Peptide Antibody Before Endoscopy.
    Mooney PD; Wong SH; Johnston AJ; Kurien M; Avgerinos A; Sanders DS
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1278-1284.e1. PubMed ID: 25632807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Sensitivity of Simtomax Point of Care Test in Detection of Celiac Disease in a Prospective Multicenter Study.
    Tangermann P; Branchi F; Itzlinger A; Aschenbeck J; Schubert S; Maul J; Liceni T; Schröder A; Heller F; Spitz W; Möhler U; Graefe U; Radke M; Trenkel S; Schmitt M; Loddenkemper C; Preiß JC; Ullrich R; Daum S; Siegmund B; Bojarski C; Schumann M
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1780-1787.e5. PubMed ID: 30267867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.
    Hopper AD; Hadjivassiliou M; Hurlstone DP; Lobo AJ; McAlindon ME; Egner W; Wild G; Sanders DS
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):314-20. PubMed ID: 18328437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.
    Wolf J; Petroff D; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Kehler T; Flemming G; Schmidt F; Rodrigues A; Hasenclever D; Mothes T
    Gastroenterology; 2017 Aug; 153(2):410-419.e17. PubMed ID: 28461188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic yield of routine duodenal biopsies in iron deficiency anaemia: a study from Western Anatolia.
    Gonen C; Yilmaz N; Yalcin M; Simsek I; Gonen O
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):37-41. PubMed ID: 17206075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Screening for Celiac Disease, Deamidated Gliadin Rarely Predicts Disease When Tissue Transglutaminase Is Normal.
    Gould MJ; Brill H; Marcon MA; Munn NJ; Walsh CM
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):20-25. PubMed ID: 30052564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of routine duodenal biopsy in diagnosing coeliac disease in patients with iron deficiency anaemia.
    Mandal AK; Mehdi I; Munshi SK; Lo TC
    Postgrad Med J; 2004 Aug; 80(946):475-7. PubMed ID: 15299158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(21):1-111. PubMed ID: 23074399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum to: 'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'.
    Lau MS; Mooney PD; White WL; Appleby V; Moreea S; Haythem I; Elias JE; Bundhoo K; Corbett GD; Wong L; Tsai HH; Cross SS; Hebden JM; Hoque S; Sanders DS
    BMC Gastroenterol; 2016 Oct; 16(1):122. PubMed ID: 27716120
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of the anti-endomysial antibody test to diagnose coeliac disease in clinical practice.
    Pearce AB; Sinclair D; Duncan HD; Saas M; Poller DN
    Clin Lab; 2002; 48(5-6):319-25. PubMed ID: 12071583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease.
    Hoerter NA; Shannahan SE; Suarez J; Lewis SK; Green PHR; Leffler DA; Lebwohl B
    Dig Dis Sci; 2017 May; 62(5):1272-1276. PubMed ID: 28161854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of an IgA/IgG-Deamidated Gliadin Peptide Point-of-Care Test in Predicting Persistent Villous Atrophy in Patients With Celiac Disease on a Gluten-Free Diet.
    Lau MS; Mooney PD; White WL; Rees MA; Wong SH; Kurien M; Trott N; Leffler DA; Hadjivassiliou M; Sanders DS
    Am J Gastroenterol; 2017 Dec; 112(12):1859-1867. PubMed ID: 29016564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease.
    Niveloni S; Sugai E; Cabanne A; Vazquez H; Argonz J; Smecuol E; Moreno ML; Nachman F; Mazure R; Kogan Z; Gomez JC; Mauriño E; Bai JC
    Clin Chem; 2007 Dec; 53(12):2186-92. PubMed ID: 17901114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a point-of-care test based on deamidated gliadin peptides for celiac disease screening in a large pediatric population.
    Bienvenu F; Besson Duvanel C; Seignovert C; Rouzaire P; Lachaux A; Bienvenu J
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1418-23. PubMed ID: 23032795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point of care testing for paediatric coeliac disease in the new ESPGHAN era.
    Lau MSY; Sanders DS
    Rev Esp Enferm Dig; 2017 Nov; 109(11):741-742. PubMed ID: 29082741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.